BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tárkányi I, Aradi J. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Biochimie 2008;90:156-72. [PMID: 17945408 DOI: 10.1016/j.biochi.2007.09.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009;54:3-10. [PMID: 19487587 DOI: 10.1161/HYPERTENSIONAHA.109.129114] [Cited by in Crossref: 202] [Cited by in F6Publishing: 71] [Article Influence: 15.5] [Reference Citation Analysis]
2 Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R, Burke H, Compagnone M, Nelson JC, Dhabhar FS, Blackburn EH. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012;17:164-72. [PMID: 21242992 DOI: 10.1038/mp.2010.133] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 8.3] [Reference Citation Analysis]
3 Qi F, Gao L, Han F. Design and synthesis of macrocyclic polyoxazoles. Chem Res Chin Univ 2014;30:587-92. [DOI: 10.1007/s40242-014-4069-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Khan S, Chuturgoon AA, Naidoo DP. Telomeres and atherosclerosis. Cardiovasc J Afr 2012;23:563-71. [PMID: 23192261 DOI: 10.5830/CVJA-2012-056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
5 Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, Sarandi E, Thanasoula M, Spandidos DA, Tsatsakis A, Razgonova MP, Calina D. Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Mol Med Rep 2019;20:3701-8. [PMID: 31485647 DOI: 10.3892/mmr.2019.10614] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gomez DE, Armando RG, Farina HG, Menna PL, Cerrudo CS, Ghiringhelli PD, Alonso DF. Telomere structure and telomerase in health and disease (review). Int J Oncol 2012;41:1561-9. [PMID: 22941386 DOI: 10.3892/ijo.2012.1611] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 9.4] [Reference Citation Analysis]
7 Adhikary A, Khanduri D, Pottiboyina V, Rice CT, Sevilla MD. Formation of aminyl radicals on electron attachment to AZT: abstraction from the sugar phosphate backbone versus one-electron oxidation of guanine. J Phys Chem B 2010;114:9289-99. [PMID: 20575557 DOI: 10.1021/jp103403p] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
8 Man RJ, Chen LW, Zhu HL. Telomerase inhibitors: a patent review (2010-2015). Expert Opin Ther Pat 2016;26:679-88. [PMID: 27104627 DOI: 10.1080/13543776.2016.1181172] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
9 Zeng X, Hernandez-Sanchez W, Xu M, Whited TL, Baus D, Zhang J, Berdis AJ, Taylor DJ. Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner. Cell Rep 2018;23:3031-41. [PMID: 29874588 DOI: 10.1016/j.celrep.2018.05.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
10 Aschacher T, Salameh O, Enzmann F, Messner B, Bergmann M. Telomere Biology and Thoracic Aortic Aneurysm. Int J Mol Sci 2017;19:E3. [PMID: 29267201 DOI: 10.3390/ijms19010003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zvereva MI, Zatsepin TS, Azhibek DM, Shubernetskaya OS, Shpanchenko OV, Dontsova OA. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics. Biochemistry (Mosc) 2015;80:251-9. [PMID: 25761680 DOI: 10.1134/S0006297915030013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
12 Jäger K, Walter M. Therapeutic Targeting of Telomerase. Genes (Basel) 2016;7:E39. [PMID: 27455328 DOI: 10.3390/genes7070039] [Cited by in Crossref: 75] [Cited by in F6Publishing: 58] [Article Influence: 12.5] [Reference Citation Analysis]
13 Ghosh S, Majumder P, Pradhan SK, Dasgupta D. Mechanism of interaction of small transcription inhibitors with DNA in the context of chromatin and telomere. Biochim Biophys Acta 2010;1799:795-809. [PMID: 20638489 DOI: 10.1016/j.bbagrm.2010.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Chen G, Da L, Wang H, Xu Y, Chen G, Sun C, Wang L, Zhao J, Zhang F, Feng J, Wang Y, Tiollais P, Li T, Zhao M. HIV-Tat–Mediated Delivery of an LPTS Functional Fragment Inhibits Telomerase Activity and Tumorigenicity of Hepatoma Cells. Gastroenterology 2011;140:332-43. [DOI: 10.1053/j.gastro.2010.08.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
15 Engin AB, Engin A. The Connection Between Cell Fate and Telomere. Adv Exp Med Biol 2021;1275:71-100. [PMID: 33539012 DOI: 10.1007/978-3-030-49844-3_3] [Reference Citation Analysis]
16 Lulkiewicz M, Bajsert J, Kopczynski P, Barczak W, Rubis B. Telomere length: how the length makes a difference. Mol Biol Rep 2020;47:7181-8. [PMID: 32876842 DOI: 10.1007/s11033-020-05551-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
17 Altschuler SE, Croy JE, Wuttke DS. A small molecule inhibitor of Pot1 binding to telomeric DNA. Biochemistry 2012;51:7833-45. [PMID: 22978652 DOI: 10.1021/bi300365k] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
18 Hwang H, Kreig A, Calvert J, Lormand J, Kwon Y, Daley JM, Sung P, Opresko PL, Myong S. Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT-associated proteins. Structure 2014;22:842-53. [PMID: 24836024 DOI: 10.1016/j.str.2014.03.013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
19 Zvereva MI, Shcherbakova DM, Dontsova OA. Telomerase: structure, functions, and activity regulation. Biochemistry (Mosc) 2010;75:1563-83. [PMID: 21417995 DOI: 10.1134/s0006297910130055] [Cited by in Crossref: 73] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
20 Kazemi-Lomedasht F, Rami A, Zarghami N. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull 2013;3:127-30. [PMID: 24312824 DOI: 10.5681/apb.2013.021] [Cited by in F6Publishing: 11] [Reference Citation Analysis]